List of Tables
Table 1. Global Cyclophosphamide for Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Cyclophosphamide for Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Cyclophosphamide for Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Cyclophosphamide for Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Cyclophosphamide for Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Cyclophosphamide for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Cyclophosphamide for Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Cyclophosphamide for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Cyclophosphamide for Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Cyclophosphamide for Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Cyclophosphamide for Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Cyclophosphamide for Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cyclophosphamide for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cyclophosphamide for Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cyclophosphamide for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Cyclophosphamide for Injection Sales by Region (K Units), 2021–2026
Table 18. Global Cyclophosphamide for Injection Sales Market Share by Region (2021–2026)
Table 19. Global Cyclophosphamide for Injection Sales by Region (K Units), 2027–2032
Table 20. Global Cyclophosphamide for Injection Sales Market Share by Region (2027–2032)
Table 21. Global Cyclophosphamide for Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Cyclophosphamide for Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Cyclophosphamide for Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Cyclophosphamide for Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Cyclophosphamide for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Cyclophosphamide for Injection Sales by Country (K Units), 2021–2026
Table 27. North America Cyclophosphamide for Injection Sales by Country (K Units), 2027–2032
Table 28. North America Cyclophosphamide for Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Cyclophosphamide for Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Cyclophosphamide for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Cyclophosphamide for Injection Sales by Country (K Units), 2021–2026
Table 32. Europe Cyclophosphamide for Injection Sales by Country (K Units), 2027–2032
Table 33. Europe Cyclophosphamide for Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Cyclophosphamide for Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Cyclophosphamide for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Cyclophosphamide for Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Cyclophosphamide for Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Cyclophosphamide for Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Cyclophosphamide for Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Cyclophosphamide for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Cyclophosphamide for Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America Cyclophosphamide for Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America Cyclophosphamide for Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Cyclophosphamide for Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Cyclophosphamide for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Cyclophosphamide for Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Cyclophosphamide for Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Cyclophosphamide for Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Cyclophosphamide for Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Cyclophosphamide for Injection Sales (K Units) by Type (2021–2026)
Table 51. Global Cyclophosphamide for Injection Sales (K Units) by Type (2027–2032)
Table 52. Global Cyclophosphamide for Injection Sales Market Share by Type (2021–2026)
Table 53. Global Cyclophosphamide for Injection Sales Market Share by Type (2027–2032)
Table 54. Global Cyclophosphamide for Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Cyclophosphamide for Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Cyclophosphamide for Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Cyclophosphamide for Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Cyclophosphamide for Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global Cyclophosphamide for Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global Cyclophosphamide for Injection Sales (K Units) by Application (2021–2026)
Table 61. Global Cyclophosphamide for Injection Sales (K Units) by Application (2027–2032)
Table 62. Global Cyclophosphamide for Injection Sales Market Share by Application (2021–2026)
Table 63. Global Cyclophosphamide for Injection Sales Market Share by Application (2027–2032)
Table 64. Global Cyclophosphamide for Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Cyclophosphamide for Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Cyclophosphamide for Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Cyclophosphamide for Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Cyclophosphamide for Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global Cyclophosphamide for Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
Table 71. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Description and Business Overview
Table 72. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Cyclophosphamide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Cyclophosphamide for Injection Product
Table 74. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 75. Shanxi Powerdone Pharmaceutics Co., Ltd. Company Information
Table 76. Shanxi Powerdone Pharmaceutics Co., Ltd. Description and Business Overview
Table 77. Shanxi Powerdone Pharmaceutics Co., Ltd. Cyclophosphamide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Shanxi Powerdone Pharmaceutics Co., Ltd. Cyclophosphamide for Injection Product
Table 79. Shanxi Powerdone Pharmaceutics Co., Ltd. Recent Developments/Updates
Table 80. Hanhui Pharmaceuticals. Company Information
Table 81. Hanhui Pharmaceuticals. Description and Business Overview
Table 82. Hanhui Pharmaceuticals. Cyclophosphamide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Hanhui Pharmaceuticals. Cyclophosphamide for Injection Product
Table 84. Hanhui Pharmaceuticals. Recent Developments/Updates
Table 85. Baxter Oncology GmbH Company Information
Table 86. Baxter Oncology GmbH Description and Business Overview
Table 87. Baxter Oncology GmbH Cyclophosphamide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Baxter Oncology GmbH Cyclophosphamide for Injection Product
Table 89. Baxter Oncology GmbH Recent Developments/Updates
Table 90. Getwell Oncology Company Information
Table 91. Getwell Oncology Description and Business Overview
Table 92. Getwell Oncology Cyclophosphamide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Getwell Oncology Cyclophosphamide for Injection Product
Table 94. Getwell Oncology Recent Developments/Updates
Table 95. Fresenius Kabi Company Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Cyclophosphamide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Fresenius Kabi Cyclophosphamide for Injection Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Amneal Pharmaceuticals, Inc. Company Information
Table 101. Amneal Pharmaceuticals, Inc. Description and Business Overview
Table 102. Amneal Pharmaceuticals, Inc. Cyclophosphamide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Amneal Pharmaceuticals, Inc. Cyclophosphamide for Injection Product
Table 104. Amneal Pharmaceuticals, Inc. Recent Developments/Updates
Table 105. Long Grove Pharmaceuticals, LLC Company Information
Table 106. Long Grove Pharmaceuticals, LLC Description and Business Overview
Table 107. Long Grove Pharmaceuticals, LLC Cyclophosphamide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Long Grove Pharmaceuticals, LLC Cyclophosphamide for Injection Product
Table 109. Long Grove Pharmaceuticals, LLC Recent Developments/Updates
Table 110. AdvaCare Pharma Company Information
Table 111. AdvaCare Pharma Description and Business Overview
Table 112. AdvaCare Pharma Cyclophosphamide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. AdvaCare Pharma Cyclophosphamide for Injection Product
Table 114. AdvaCare Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Cyclophosphamide for Injection Distributors List
Table 118. Cyclophosphamide for Injection Customers List
Table 119. Cyclophosphamide for Injection Market Trends
Table 120. Cyclophosphamide for Injection Market Drivers
Table 121. Cyclophosphamide for Injection Market Challenges
Table 122. Cyclophosphamide for Injection Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cyclophosphamide for Injection
Figure 2. Global Cyclophosphamide for Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Cyclophosphamide for Injection Market Share by Type: 2025 & 2032
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Cyclophosphamide for Injection Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Cyclophosphamide for Injection Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Cyclophosphamide for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Cyclophosphamide for Injection Market Size (US$ Million), 2021–2032
Figure 13. Global Cyclophosphamide for Injection Sales (K Units), 2021–2032
Figure 14. Global Cyclophosphamide for Injection Average Price (US$/Unit), 2021–2032
Figure 15. Cyclophosphamide for Injection Report Years Considered
Figure 16. Cyclophosphamide for Injection Sales Share by Manufacturers in 2025
Figure 17. Global Cyclophosphamide for Injection Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Cyclophosphamide for Injection Players: Market Share by Revenue in Cyclophosphamide for Injection in 2025
Figure 19. Cyclophosphamide for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Cyclophosphamide for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Cyclophosphamide for Injection Sales Market Share by Country (2021–2032)
Figure 22. North America Cyclophosphamide for Injection Revenue Market Share by Country (2021–2032)
Figure 23. United States Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Cyclophosphamide for Injection Sales Market Share by Country (2021–2032)
Figure 26. Europe Cyclophosphamide for Injection Revenue Market Share by Country (2021–2032)
Figure 27. Germany Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Cyclophosphamide for Injection Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Cyclophosphamide for Injection Revenue Market Share by Region (2021–2032)
Figure 34. China Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Cyclophosphamide for Injection Sales Market Share by Country (2021–2032)
Figure 42. Latin America Cyclophosphamide for Injection Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Cyclophosphamide for Injection Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Cyclophosphamide for Injection Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Cyclophosphamide for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Cyclophosphamide for Injection by Type (2021–2032)
Figure 53. Global Revenue Market Share of Cyclophosphamide for Injection by Type (2021–2032)
Figure 54. Global Cyclophosphamide for Injection Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Cyclophosphamide for Injection by Application (2021–2032)
Figure 56. Global Revenue Market Share of Cyclophosphamide for Injection by Application (2021–2032)
Figure 57. Global Cyclophosphamide for Injection Price (US$/Unit) by Application (2021–2032)
Figure 58. Cyclophosphamide for Injection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
